SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001731122-21-001347
Filing Date
2021-08-12
Accepted
2021-08-12 17:13:09
Documents
40
Period of Report
2021-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q e3018_10-q.htm   iXBRL 10-Q 591731
2 EXHIBIT 31.1 e3018_ex31-1.htm EX-31.1 7246
3 EXHIBIT 31.2 e3018_ex31-2.htm EX-31.2 7959
4 EXHIBIT 32.1 e3018_ex32-1.htm EX-32.1 6381
5 GRAPHIC image_001.jpg GRAPHIC 202924
6 GRAPHIC image_002.jpg GRAPHIC 94832
  Complete submission text file 0001731122-21-001347.txt   3216725

Data Files

Seq Description Document Type Size
7 XBRL SCHEMA FILE avxl-20210630.xsd EX-101.SCH 22874
8 XBRL CALCULATION FILE avxl-20210630_cal.xml EX-101.CAL 25517
9 XBRL DEFINITION FILE avxl-20210630_def.xml EX-101.DEF 76819
10 XBRL LABEL FILE avxl-20210630_lab.xml EX-101.LAB 190436
11 XBRL PRESENTATION FILE avxl-20210630_pre.xml EX-101.PRE 141724
12 EXTRACTED XBRL INSTANCE DOCUMENT e3018_10-q_htm.xml XML 312528
Mailing Address 51 W 52ND STREET, 7TH FLOOR NEW YORK NY 10019-6163
Business Address 51 W 52ND STREET, 7TH FLOOR NEW YORK NY 10019-6163 800-689-3939
ANAVEX LIFE SCIENCES CORP. (Filer) CIK: 0001314052 (see all company filings)

IRS No.: 208365999 | State of Incorp.: NV | Fiscal Year End: 0930
Type: 10-Q | Act: 34 | File No.: 001-37606 | Film No.: 211168676
SIC: 8731 Services-Commercial Physical & Biological Research